Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins
Authors:
- 22 February 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 226 (12) , 3355-3367
Abstract
BRCA1 gene mutations are responsible for hereditary breast and ovarian cancers. In sporadic breast tumors, BRCA1 dysfunction or aberrant subcellular localization is thought to be common. BRCA1 is a nuclear–cytoplasm shuttling protein and the reason for cytoplasmic localization of BRCA1 in young breast cancer patients is not yet known. We have previously reported BRCA1 proteins unlike K109R and cancer‐predisposing mutant C61G to bind Ubc9 and modulate ER‐α turnover. In the present study, we have examined the consequences of altered Ubc9 binding and knockdown on the subcellular localization and growth inhibitory function of BRCA1 proteins. Our results using live imaging of YFP, GFP, RFP‐tagged BRCA1, BRCA1a and BRCA1b proteins show enhanced cytoplasmic localization of K109 R and C61G mutant BRCA1 proteins in normal and cancer cells. Furthermore, down‐regulation of Ubc9 in MCF‐7 cells using Ubc9 siRNA resulted in enhanced cytoplasmic localization of BRCA1 protein and exclusive cytoplasmic retention of BRCA1a and BRCA1b proteins. These mutant BRCA1 proteins were transforming and impaired in their capacity to inhibit growth of MCF‐7 and CAL51 breast cancer cells. Interestingly, cytoplasmic BRCA1a mutants showed more clonogenicity in soft agar and higher levels of expression of Ubc9 than parental MCF7 cells. This is the first report demonstrating the physiological link between cytoplasmic mislocalization of mutant BRCA1 proteins, loss of ER‐α repression, loss of ubiquitin ligase activity and loss of growth suppression of BRCA1 proteins. Thus, binding of BRCA1 proteins to nuclear chaperone Ubc9 provides a novel mechanism for nuclear import and control of tumor growth. J. Cell. Physiol. 226: 3355–3367, 2011.Keywords
This publication has 46 references indexed in Scilit:
- The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcomeBlood, 2010
- BRCA1 Regulates Acetylation and Ubiquitination of Estrogen Receptor-αMolecular Endocrinology, 2010
- Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent mannerOncogene, 2009
- Common variants in the UBC9 gene encoding the SUMO‐conjugating enzyme are associated with breast tumor gradeInternational Journal of Cancer, 2009
- E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaksProceedings of the National Academy of Sciences, 2008
- Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactionsOncogene, 2008
- SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancyNucleic Acids Research, 2007
- Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteinsThe EMBO Journal, 2007
- Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligaseProceedings of the National Academy of Sciences, 2007
- Expression Profiles of BRCA1 Splice Variants in Asynchronous and in G1/S Synchronized Tumor Cell LinesBiochemical and Biophysical Research Communications, 2001